Supported by

Left main and multivessel disease

Find all the latest content on left main and multivessel disease published on this website.

The left main coronary artery provides the primary source of blood flow to the left ventricle. Diseases affecting the left main, by itself or in combination with multivessel disease, place the patient at significant risk for life-threatening cardiovascular events. Treatment requires an understanding of all available tools, devices and techniques, like those employed in invasive imaging and functional assessment, as well as taking into account underlying comorbidities such as diabetes. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks. Use the filters below to access PCRonline resources.

Filtered By
Left main and multivessel disease

422 results

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with left main disease with and without diabetes: findings from a pooled analysis of 4 randomized clinical trials

30 Apr 2024

This analysis shows that diabetic patients undergoing revascularization face substantially higher 5-year rates of all-cause mortality, myocardial infarction, repeat revascularizations, and stroke compared to non-diabetic patients.

Alessandro Sticchi

Reviewer

Alessandro Sticchi
Prof. Antonio Colombo

Reviewer

Antonio Colombo
PCI vs CABG in patients with LM disease with and without diabetes: findings from a pooled analysis of 4 randomized clinical trials

Tailoring PCI: from full metal jacket to waistcoat

12 Feb 2024

A 38-year-old man with class III angina was referred for coronary angiography following a positive myocardial perfusion scan. The angiogram showed functionally occluded PDA as well as significant disease in the proximal, mid, and distal RCA. After wiring and predilating PDA, TIMI-III flow in PDA was...

Pr. Marcus Wiemer

Author

Marcus Wiemer
Dr. D.Pascut

Author

Dan Pascut
Tailoring PCI: from full metal jacket to a waistcoat

EuroIntervention: your academic reference journal for coronary, valvular and structural interventions

07 Feb 2024

EuroIntervention Journal is an international, English language, peer-reviewed journal which publishes high quality academic research in coronary, valvular, structural and surgical cardiovascular interventions.

EuroIntervention: Your reference journal for coronary, valvular and structural interventions

Five most impactful trials in 2023

02 Jan 2024 – From GulfPCR-GIM 2023

Find out how, based on an initial clinical situation, the scientific evidence gathered between January and December on the key subjects selected for 2023, focusing on coronary issues, might have had an impact on daily practice, or is encouraging changes in practice, from MVD in ACS...

Five most impactful trials in 2023

A stuck Rota burr in a "flintstone" coronary artery

18 Dec 2023

Step by Step video on how to deal with a stuck Rota burr with the same arterial access. Nice example of Kokeshi phenomenon.

Jorge Andres Chavarria Viquez

Author

Jorge Andres Chavarria Viquez
Adrián Lostalo

Author

Adrián Lostalo
A stuck Rota burr in a 'flintstone' coronary artery

Navigating complexity: surgical valve degeneration and complex coronary artery disease in a multimorbid patient

14 Dec 2023

How would you treat this 83-year-old male patient with LM, MVD, RCA CTO, severely reduced EF, and constrictive surgical valve?

Sadeek Sidney Kanoun Schnur

Author

Sadeek Sidney Kanoun Schnur

Author

Albrecht Schmidt
Dr. Gabor G. Toth

Author

Gabor G. Toth
Navigating complexity: surgical valve degeneration and complex CAD in a multimorbid patient

Dapagliflozin in acute myocardial infarction: Cardiometabolic benefits without impact on cardiovascular death or heart failure hospitalization: The jury is still out

14 Nov 2023

Luis Ortega Paz provides his take on DAPA-MI - A registry-based randomized trial of dapagliflozin in patient with acute myocardial infarction without diabetes, which was presented by Stefan James at AHA 2023 in Philadelphia.

Luis Ortega-Paz

Author

Luis Ortega-Paz
DAPA-MI - A registry-based randomized trial of dapagliflozin in patient with acute myocardial infarction without diabetes

Navigating challenges in left main lesions

22 Sep 2023 – From AICT-AsiaPCR 2023

Dive into the world of left main coronary artery issues through these presentations, and discover how they tackle challenging scenarios, from cathlab nightmares and syncope management to complex left main bifurcation procedures and primary angioplasty in cardiogenic shock patient with prior angioplasty history.

Navigating challenges in left main lesions

Strategies for unexpected stable CAD complications

22 Sep 2023 – From AICT-AsiaPCR 2023

Join us for this session as experts recount their experiences in successfully managing unexpected complications. Learn about a remarkable bailout of iatrogenic dissection in the right coronary artery, the challenges of severe catheter kinking and entrapment during transradial coronary angiography, and much more!

Strategies for unexpected stable CAD complications

The importance of SEE-PREP-TREAT in left main bifurcation

22 Sep 2023 – From AICT-AsiaPCR 2023

This session is recommended for you if you are seeking insights into the advantages of using IVUS imaging over visual assessment for better outcomes in left main bifurcation procedures. Discuss with experts the benefits of using RotaCUT in lesion preparation for left main bifurcation and explore...

The importance of SEE-PREP-TREAT